Clinical Significance of HER2-low Breast Cancer

被引：0
|
作者：
Zaiem, Fadi
AbuJamea, Asem
Kheil, Mira
Numi, Anna
Abbas, Omar
Awada, Sanaa
Almsaddi, Ragad
Al-Juburi, Saleh
Larson, Lauren
Jain, Deepti
AlSaghir, Maya
Jang, Hyejeong
Kim, Seongho
Bandyopadhyay, Sudeshna
Jaiman, Sunil
Ali-Fehmi, Rouba
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO3-01-11
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO3-01-11
引用
收藏
页数：3
相关论文
共 50 条
  • [21] HER2-Low Breast Cancer: Now and in the Future
    Kang, Sora
    Kim, Sung-Bae
    CANCER RESEARCH AND TREATMENT, 2024, 56 (03): : 700 - 720
  • [22] Current Biological, Pathological and Clinical Landscape of HER2-Low Breast Cancer
    Zhang, Huina
    Peng, Yan
    CANCERS, 2023, 15 (01)
  • [23] Clinical, pathological and gene expression features of HER2-low breast cancer
    Schettini, F.
    Chic, N.
    Braso-Maristany, F.
    Pare, L.
    Pascual, T.
    Conte, B.
    Martinez-Saez, O.
    Adamo, B.
    Vidal, M.
    Fernandez-Martinez, A.
    Gonzalez-Farre, B.
    Sanfeliu, E.
    Perrone, G.
    Villagrasa, P.
    Gavila Gregori, J.
    Barrios, C. H.
    Lluch, A.
    Martin Jimenez, M.
    De Placido, S.
    Prat, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S24 - S24
  • [24] PREVALENCE AND CLINICAL FEATURES OF HER2-LOW BREAST CANCER AMONG UKRAINIAN POPULATION
    Bondar, Maryna
    Tarasenko, Tetiana
    Martyniuk, Olena
    Syvak, Liubov
    BREAST, 2023, 71 : S54 - S54
  • [25] Clinical features, genomic landscapes, and survival outcomes of HER2-low breast cancer
    Juan, Jin
    Li, Bin
    Wang, Biyun
    Tao, Zhonghua
    Hu, Xichun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Clinical characteristics, metastasis patterns, and treatment outcomes of HER2-low breast cancer
    Lacruz, Maria Elena
    Thies, Saskia
    Schmidt-Pokrzywniak, Andrea
    Wittenberg, Ian
    Engler, Tobias
    Reinwald, Fabian
    Klinkhammer-Schalke, Monika
    Zeissig, Sylke Ruth
    Franke, Bianca
    Weitmann, Kerstin
    Ignatov, Atanas
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [27] Clinical outcomes in women with metastatic HER2-Low breast cancer in the real world
    Jiang, Changchuan
    Perimbeti, Stuthi
    Deng, Lei
    Shapiro, Charles L.
    Gandhi, Shipra
    CANCER RESEARCH, 2022, 82 (12)
  • [28] HER2-Low expression in primary male breast cancer
    Rudlowski, Christian
    Erices-Leclercq, Melanie
    Nobbe, Katleen
    Baldus, Stephan
    Foerster, Robert
    Foerster, Frank
    Lubig, Sabine
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 29 - 29
  • [29] Genomic and Transcriptomic Landscape of HER2-Low Breast Cancer
    Bansal, Rani
    McGrath, Julie
    Walker, Phil
    Bustos, Matias A.
    Rodriguez, Estelamari
    Sammons, Sarah L.
    Accordino, Melissa K.
    Meisel, Jane
    Gatti-Mays, Margaret
    Hsu, Emily
    Lathrop, Kate I.
    Kaklamani, Virginia
    Oberley, Matthew
    Korn, W. Michael
    Graff, Stephanie L.
    CANCER RESEARCH, 2023, 83 (05)
  • [30] Comprehensive genomic characterization of HER2-low breast cancer
    Tarantino, Paolo
    Gupta, Hersh V.
    Hughes, Melissa E.
    Files, Janet L.
    Strauss, Sarah
    Kirkner, Gregory
    Feeney, Anne-Marie
    Li, Yvonne Y.
    Garrido-Castro, Ana C.
    Barroso-Sousa, Romualdo
    Bychkovsky, Brittany
    MacConaill, Laura
    Lindeman, Neal
    Johnson, Bruce
    Meyerson, Matthew
    Kabraji, Sheheryar
    Jeselsohn, Rinath
    Qiu, Xintao
    Li, Rong
    Long, Henry W.
    Winer, Eric
    Dillon, Deborah A.
    Curigliano, Giuseppe
    Cherniack, Andrew
    Tolaney, Sara
    Lin, Nancy U.
    CANCER RESEARCH, 2023, 83 (05)
12345